Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2468691000168119 | Agenerase (amprenavir 150 mg) capsule, 240 capsules, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2468701000168119 | Agenerase 150 mg capsule, 240, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agenerase 150 mg capsule, 240, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule, 240, bottle | Is a | Agenerase 150 mg capsule, 240 | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule, 240, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule, 240, bottle | has TPUU | Agenerase 150 mg capsule | true | Inferred relationship | Some | 1 | |
| Agenerase 150 mg capsule, 240, bottle | has TP | Agenerase | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR